Home / TBX1 Knockout Cell Lines

TBX1 Knockout Cell Lines

Gene: TBX1

Official Full Name: T-box transcription factor 1provided by HGNC

Gene Summary: This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene product shares 98% amino acid sequence identity with the mouse ortholog. DiGeorge syndrome (DGS)/velocardiofacial syndrome (VCFS), a common congenital disorder characterized by neural-crest-related developmental defects, has been associated with deletions of chromosome 22q11.2, where this gene has been mapped. Studies using mouse models of DiGeorge syndrome suggest a major role for this gene in the molecular etiology of DGS/VCFS. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO09841 TBX1 Knockout cell line (HeLa) Human TBX1 1:3~1:6 Negative Online Inquiry
KO09842 TBX1 Knockout cell line (HEK293) Human TBX1 1:3~1:6 Negative Online Inquiry
KO09843 TBX1 Knockout cell line (A549) Human TBX1 1:3~1:4 Negative Online Inquiry

Background

TBX1 Gene Knockout Cell Lines are genetically engineered cell lines in which the TBX1 gene, known for its critical role in embryonic development and cardiovascular formation, has been specifically disrupted. The knockout is achieved through advanced CRISPR-Cas9 technology, allowing precise editing of the genome to create a model that closely mimics the pathological conditions associated with the 22q11.2 deletion syndrome. This knockout strategy inhibits the expression of the TBX1 gene, facilitating studies on the gene's function in cellular processes and its implications in disease.

These cell lines serve as powerful tools for dissecting the molecular mechanisms underlying various developmental disorders, particularly those related to congenital heart defects. The absence of TBX1 provides researchers with a unique platform to study gene interactions, signaling pathways, and potential therapeutic targets. Moreover, the TBX1 knockout cell lines can be utilized to assess drug efficacy, toxicology, and the impact of environmental factors on gene expression, making them invaluable in both research and preclinical applications.

Compared to traditional cell lines, the TBX1 gene knockout models offer the specificity and relevance necessary for accurate modeling of disease states. They minimize confounding variables, enabling researchers to draw clear conclusions regarding the influence of TBX1 on cellular functions. This specificity enhances the reproducibility of research outcomes, a key aspect for the scientific community.

In addition, our TBX1 Gene Knockout Cell Lines are developed under strict quality standards, ensuring high viability and stability for long-term studies. These lines are readily available and compatible with various assays, making them an attractive option for labs seeking reliability and efficiency.

By choosing our TBX1 Gene Knockout Cell Lines, researchers and clinicians can leverage state-of-the-art models that are supported by our company’s commitment to excellence in genetic engineering and cell line development. Our expertise ensures that you receive not only superior products but also the scientific support needed to advance your research and therapeutic efforts.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.